Camille Samuels Net Worth

Camille Samuels biography

Camille D. Samuels is Independent Director of the Company. Ms. Samuels has been a Partner of Venrock, a venture capital firm, since May 2014. Prior to that, she served as a Managing Director of Versant Ventures, a life sciences venture capital firm, from February 2000 to December 2012. She previously served as a board member or a board observer on other public healthcare companies, including Achaogen, Inc., Carmenta Biosciences, Fluidigm Corporation, Genomic Health, Inc., KYTHERA, Novacardia, Inc., ParAllele BioScience, Inc., RegenXBIO and Syrrx. Prior to her venture career, Ms. Samuels held business development and strategic marketing roles at Tularik Inc., a public biotechnology company, acquired by Amgen and Genzyme Corp. Ms. Samuels received a B.A. in Biology from Duke University and an M.B.A. from Harvard Business School, both with high distinction.

What is the salary of Camille Samuels?

As the Independent Director of Unity Biotechnology Inc, the total compensation of Camille Samuels at Unity Biotechnology Inc is $220,080. There are 11 executives at Unity Biotechnology Inc getting paid more, with Keith Leonard having the highest compensation of $3,270,820.

How old is Camille Samuels?

Camille Samuels is 49, she's been the Independent Director of Unity Biotechnology Inc since 2015. There are 20 older and 2 younger executives at Unity Biotechnology Inc. The oldest executive at Unity Biotechnology Inc is David Lacey, 67, who is the Independent Director.

What's Camille Samuels's mailing address?

Camille's mailing address filed with the SEC is C/O UNITY BIOTECHNOLOGY, INC., 285 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080.

Insiders trading at Unity Biotechnology Inc

Over the last 6 years, insiders at Unity Biotechnology Inc have traded over $9,012,473 worth of Unity Biotechnology Inc stock and bought 3,200 units worth $28,480 . The most active insiders traders include Kristina Burow, Robert Nelsen a Nathaniel E David. On average, Unity Biotechnology Inc executives and independent directors trade stock every 54 days with the average trade being worth of $65,316. The most recent stock trade was executed by Alexander Hieu Nguyen on 2 August 2024, trading 154 units of UBX stock currently worth $236.

What does Unity Biotechnology Inc do?

unity biotechnology is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. unity's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases. more information is available at www.unitybiotechnology.com.

Unity Biotechnology Inc executives and stock owners

Unity Biotechnology Inc executives and other stock owners filed with the SEC include:

• Keith Leonard,
  Chairman of the Board
• Margo Roberts,
  Independent Director
• Nathaniel David,
  President, Co-Founder, Director
• Dr. Anirvan Ghosh,
  CEO & Director
• Dr. Jamie Dananberg M.D.,
  Chief Medical Officer
• Dr. Jamie Dananberg,
  Chief Medical Officer
• Lynne Marie Sullivan,
  CFO & Head of Corp. Devel.
• Paul Berns,
  Independent Director
• Graham Cooper,
  Independent Director
• David Lacey,
  Independent Director
• Kristina Burow,
  Independent Director
• Camille Samuels,
  Independent Director
• Robert Nelsen,
  Director
• Dr. Nathaniel E. David A.B., Ph.D.,
  Co-Founder & Exec. Director
• Luis Visoso,
  Director
• Mary Campbell,
  Director
• Jamie Dananberg,
  Chief Medical Officer
• Tamara Tompkins,
  General Counsel and Corporate Secretary
• Dan Marquess,
  Chief Scientific Officer
• Lynne Sullivan,
  Chief Financial Officer, Chief Accounting Officer
• Anirvan Ghosh,
  Chief Executive Officer, Director
• Dr. Nathaniel E. David,
  Co-Founder & Exec. Director
• Susan Lundeen Smuck,
  Chief HR Officer
• Dr. Przemyslaw Sapieha Ph.D.,
  Chief Scientific Advisor
• Alexander Azoy,
  VP of Fin., Chief Accounting Officer, Controller & Principal Accounting Officer
• Nathan Guz Ph.D.,
  VP of Operations
• Daohong Zhou M.D.,
  Founder
• Dr. Judith Campisi,
  Founder
• Dr. Jan M. van Deursen,
  Founder
• Alexander Azoy,
  See Remarks
• Alexander Hieu Nguyen,
  Chief Legal Officer
• Ii Robert C. Goeltz,
  Chief Financial Officer
• Venture Partners Vii, Llcar...,
  
• Michael P. Samar,
  
• Gilmore Neil O'neill,